A Methodology Study to Assess the Feasibility of Using Functional Magnetic Resonance Imaging to Quantify the Effects of Analgesic Drugs in Post-Traumatic Neuropathic Pain Subjects.

Trial Profile

A Methodology Study to Assess the Feasibility of Using Functional Magnetic Resonance Imaging to Quantify the Effects of Analgesic Drugs in Post-Traumatic Neuropathic Pain Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2013

At a glance

  • Drugs Pregabalin; Tramadol
  • Indications Neuropathic pain
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 30 Nov 2012 Actual patient number changed from 20 to 18 as reported by ClinicalTrials.gov.
    • 16 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Sep 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top